TNFSF13B and B-cell chronic lymphocytic leukemia: Our results suggest that blocking the BAFF-BAFF-R axis in combination with existing therapies could potentially achieve two goals; reduce tumor burden in the periphery and eliminate the supply of more aggressive precursor CLL cells.